Most Active Stocks

BSE
JPPOWER
KOTAKBANK
TITAN
INDIASHLTR
WAAREEENER
ADANIPOWER
VTL
HDFCBANK
MCX
CDSL
ALOKINDS
RTNPOWER
BEL
GOKEX
BELRISE
ANGELONE
TRENT
HAL
TATAMOTORS

Ind-Swift Laboratories Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is headquartered in Manimajra, India.

Key Information

Market Cap

6945713664

Current Price

114.58

52 Week Range

68.72 - 186.0

Previous Close

114.59

Open

115.26

Contact Details

Address

Shivalik Enclave, SCO 850 NAC, Manimajra, 160101, India

Phone

+91-17250-61850

Fax

+91-17227-30504

Financials

Day Low

113.61

Day High

116.5

Dividend Yield

PE Ratio

1.9125355

Earnings Per Share

59.91

Beta

0.303

EBITDA

914329472

Book Value

171.283

EPS

Company Officers

Name Title Age Year Born
Mr. Navrattan R. Munjal Chairman & MD 72 1952
Mr. Himanshu Jain BCom Joint MD & Whole Time Director 42 1982
Mr. Rishav Mehta Executive Director 33 1991
Mr. Sahil Munjal Executive Director 44 1980
Mr. Gagan Aggarwal Chief Financial Officer - -
Ashok Kothari General Manager of Information & Technology - -
Mr. Pardeep Verma VP of Corporate Affairs, Compliance Officer & Company Secretary - -
Varun Chhabra Senior Vice President of Marketing - -
Akashdeep Sharma Group HR Head - -

Company Details

Stock History